IASLC/X
Feb 7, 2025, 08:23
The recent FDA approval of osimertinib after chemo-radiation in EGFR-positive NSCLC – IASLC
IASLC shared a post on X:
Catch the new episode of Lung Cancer Considered as Narjust Florez and Pamela Samson discuss the recent FDA approval of osimertinib after chemo-radiation in EGFR-positive NSCLC, based on the LAURA trial.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 7, 2025, 08:20
Feb 7, 2025, 08:19
Feb 7, 2025, 08:14
Feb 7, 2025, 07:57
Feb 7, 2025, 07:52
Feb 7, 2025, 07:45
Feb 6, 2025, 16:53
Feb 6, 2025, 16:46
Feb 6, 2025, 16:43